Abstract
Ponatinib produces a coronary microangiopathy that mimics myocardial infarction and can be detected rapidly by contrast echocardiography.
N-acetylcysteine therapy can potentially resolve ischemic complications caused by ponatinib-related microangiopathy.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Acetylcysteine / therapeutic use
-
Humans
-
Imidazoles / therapeutic use
-
Pyridazines*
-
Vascular Diseases*
Substances
-
Imidazoles
-
Pyridazines
-
ponatinib
-
Acetylcysteine